Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis.
Berberine can inhibit the proliferation and metastasis of EC cells and promote apoptosis, which is related to the concentration.
Uterine Cancer · LIVING RESEARCH LIBRARY
Ongoing Research for Uterine Cancer Using Advanced Alternative Medicine
Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.
Every entry includes the original study title, year, concise finding and a direct PubMed link.
Call 1.800.923.7878Ask About Your Uterine Cancer Case
Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.
Prefer to speak now?
Call 1.800.923.7878
Living research library · positive published findingsOpen study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed → Open study on PubMed →
Research organized by substance and finding
Browse 13 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.
Open study on PubMed →
Liposomal Curcumin Targeting Endometrial Cancer Through the NF-κB Pathway.
In vitro, LC resulted in dose-dependent inhibition of proliferation, induction of apoptosis, and suppression of Ishikawa and HEC-1 cell motility.
Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer.
Sulfasalazine treatment significantly decreased intracellular glutathione levels and induced apoptosis when combined with cisplatin in USC cell lines.
Melatonin suppresses tumor proliferation and metastasis by targeting GATA2 in endometrial cancer.
In addition, in vivo and in vitro experiments showed that MT inhibited the proliferation and metastasis of EC cells by upregulating GATA2 expression.
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
Here, exploratory studies of the gut microbiome (GM) are presented.
Interactions between microbiota and uterine corpus endometrial cancer: A bioinformatic investigation of potential immunotherapy.
In this regard, we used the same deconvolution of the TCGA database to analyze the microbiome that have a strong association with immune cells invasion with TME of UCEC patients.
Intratumor microbiome-derived butyrate enhances progesterone sensitivity by inducing ferroptosis in endometrial cancer.
This study is the first to demonstrate the critical role of the EC tumor microbiome and its metabolite butyrate in modulating progesterone response in FPT.
Microbiome impacts quality of life in patients with endometrial cancer and benign gynecological conditions.
We offer preliminary findings for foundational knowledge for future opportunities on improvement of QOL through microbiome modulation.
Integrating network pharmacology to investigate the mechanism of quercetin's action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer.
Quercetin, a widely distributed natural flavonoid, has demonstrated potential therapeutic effects in managing both PCOS and EC.
Quercetin suppresses endometrial cancer stem cells via ERα-mediated inhibition of STAT3 signaling.
This study aimed to evaluate the anti-tumor effects of Quercetin by targeting CSCs and suppressing their stemness properties.
Dual effects of metformin and resveratrol on compromising viability of endometrial cancer cells.
Metformin, commonly used for treating type 2 diabetes, and resveratrol, a natural polyphenol, can both decrease cancer cell proliferation by modulating the PI3K/Akt/mTOR pathway.
High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer in vitro and in vivo.
In this study, high-dose ascorbate significantly inhibited cell proliferation and invasion, increased cellular stress and DNA damage, and induced cell cycle arrest and apoptosis in EC cells.
Retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP.
The study reports retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP.
No studies match those filters. Clear a filter or try a broader term.